2MD (DP001), a Single Agent in the Management of Hemodialysis Patients: A Randomized Trial.

CONCLUSION: DP001 safely and effectively suppressed iPTH in hemodialysis patients with SHPT that were previously managed with active vitamin D alone or with a calcimimetic (www.clinicaltrials.gov, NCT01922843).
PMID: 27880946 [PubMed - as supplied by publisher]

Source: American Journal of Nephrology - November 23, 2016 Category: Urology & Nephrology Authors: Thadhani R, Zella JB, Knutson DC, Blaser WJ, Plum LA, Clagett-Dame M, Buck RD, DeLuca HF Tags: Am J Nephrol Source Type: research